Yrityksen palveluksessa oli noin 10 000 ihmistä. PRESENT.

[5][6][7][8] The company manufactures and custom synthesizes generic APIs, intermediates and nutraceutical ingredients. Enjoy Reading! The inspection was focused on follow up on the effectiveness of the CAPA implemented from the last JAZMP inspection and general GMP inspection of the site. On 22 April 2017 Divi's Laboratories announced that the US-FDA has issued a warning letter for the company's Unit-II at Visakhapatnam.

The DSN SEZ Unit commenced commercial operations from June 1 2011.During the year 2012-13 the company added 9 products to its product portfolio of which 3 are generic APIs and intermediates and 6 are custom synthesis APIs and intermediates.In 2014 the Korean Food and Drug Administration (KFDA) carried out inspection of the company's Visakhapatnam Unit-2 for the third time. Wiki Main page Random page FAQ / Contact Rules Types of article Contribute ! Divi's Laboratories Ltd. 01/1990–UNKNOWN.

The company went for initial public offering (IPO) and their shares were listed on Bombay Stock Exchange and National Stock Exchange.In the year 2004 the company invested an amount of Rs 3035.21 lakh towards capital expenditure at their manufacturing facilities at Choutuppal (Unit-I) and Chippada (Unit-II) for additional machinery installed at both Unit-I and Unit-II. Divi's Laboratories Limited is an Indian producer of active pharmaceutical ingredients (APIs) and intermediates headquartered in Hyderabad, Telangana, India. [11], Divi's Laboratories was established in 1990 as Divi's Research Centre. Divis Laboratories Ltd. (tai Divi's Laboratories Ltd.) on intialainen lääketeollisuusyhtiö.

Create a bio Create a company page Musical album Other pages Topics ️Wiki map .

The company initially started developing commercial processes for the manufacturing of APIs and intermediates.

In the year 2001 the company received OHSAS-18001 Certification from BVQI of London for their Occupational Health and Safety Management Systems.In the year 2002 the company commenced setting up of their second manufacturing facility (Unit II) at Chippada near Visakhapatnam. [9][10] Divi's Laboratories is India's second most valuable pharmaceutical company by market capitalization. Chairman.

This article "Divi's Laboratories" is from Wikipedia. Company History - Divi's Laboratories Ltd. Milestones: 1990 -Divis Research Center (DRC) established. This page was last edited on 18 October 2020, at 15:58. Board Member. Dr. Reddy's Laboratories is an Indian multinational pharmaceutical company located in Hyderabad, Telangana, India. Business Standard is happy to inform you of the launch of "Business Standard Premium Services". In the year 2006 the company received letter of approval from Ministry of Commerce Government of India for setting up a sector-specific special economic zone (SEZ) for pharmaceutical ingredients at Chippada Bheemunipatnam in Visakhapatnam with investment of Rs 200 crore. [14][15] In 2010, the company established a research centre in Hyderabad.

During the year COFEPRIS (Mexico) inspected the company's Visakhapatnam Unit-2 for the first time. Se tuottaa aktiivisia farmaseuttisia ainesosia (API) ja välivaiheen yhdisteitä geneeristen lääkkeiden valmistamiseksi. Divis Laboratories USA Inc. The second manufacturing unit is an export oriented unit located at village Chippada Bheemunipatnam Mandal about 30 KM from the port city of Visakhapatnam (Andhra Pradesh) on the east coast situated on a 100-acre site. During the year 1991-93 the company successfully developed several commercial processes for intermediates and bulk actives and supplies to manufacturing majors.

The third facility is located at village Chippda situated on a sprawling 267-acre site and is a Special Economic Zone (SEZ) Unit in Pharma Sector. Divi's Research Centre changed its name to Divi's Laboratories Limited in 1994 to signal its intent to enter the API and intermediates manufacturing industry. As a premium subscriber you get an across device unfettered access to a range of services which include: Welcome to the premium services of Business Standard brought to you courtesy FIS.

Maaliskuussa 2015 yhtiöllä oli neljä tuotantolaitosta ja neljä tutkimuskeskusta Intiassa sekä tytäryhtiöt Sveitsissä ja Yhdysvalloissa. The company is engaged in manufacture of leading generic compounds Nutraceutical ingredients and custom synthesis of APIs and intermediates for global innovator companies.
2014 -Divis Laboratories Ltd. has recommended a dividend of 1000% i.e.
During the year 2009-10 they added 7 products to their product portfolio of which 2 are generic APIs and intermediates and 5 are custom synthesis APIs and intermediates.During the year 2010-11 the company added 21 products to their product portfolio of which 8 are generic APIs and intermediates and 13 are custom synthesis APIs and intermediates.

By using our services, you agree to our use of cookies. … They commissioned Nutraceuticals Manufacturing facility at Divi's Pharma SEZ and commenced commercial operations effective June 1 2008.During the year 2008-09 the company added 9 products to their product portfolio of which 4 are generic APIs and intermediates and 5 are custom synthesis APIs and intermediates.

On 15 November 2017 Divi's Laboratories announced that the US-FDA has lifted/removed import alert 66-40 imposed on the company's Unit-II at Visakhapatnam.On 18 November 2017 Divi's Laboratories announced that the company has received an Establishment Inspection Report (EIR) from US-FDA for Unit-II at Visakhapatnam as closure of audit by FDA. [13], The company went public with its IPO on 17 February 2003.

The company was founded by Anji Reddy, who previously worked in the mentor institute Indian Drugs and Pharmaceuticals Limited. 2/- face value for the year ended March 31, 2014. The company has Research Centers at Sanathnagar, Hyderabad and at the manufacturing sites. Also during the year fifth US FDA inspection was carried out for Unit-1. The company has Research Centers at Sanathnagar Hyderabad and at the manufacturing sites.

Divi's Laboratories Ltd. 08/2004–04/2020.

Divis Laboratories (USA) Inc. in the United States of America and M/s.

[13] In 2002, the company's second manufacturing facility commenced operations at Chippada near Visakhapatnam. COFEPRIS (Mexico) also inspected the company's Choutuppal Unit-1 in Telangana for the first time in the year 2014.On 19 February 2016 Divi's Laboratories announced that it has had a successful inspection by the US-FDA for its Unit-2 at Chippada Bheemunipatnam near Visakhapatnam during February 2016 with no observations.The Board of Directors of Divi's Laboratories at its meeting held on 12 August 2016 approved and ratified one-time ex-gratia of an aggregate amount of Rs 79 crore to the employees and whole-time directors of the company on the occasion of completion of 25 years of formation of the company.

Sivua on viimeksi muutettu 7. toukokuuta 2018 kello 04.14. Articles by topic Biographies ️Cinema Sport Music ️Organisation Follow us!

[3], Alkuvuodesta 2018 alussa Divis Laboratories oli yksi Intian kymmenestä suurimmasta lääketehtaista ja kuului markkina-arvoltaan Bombayn pörssin 100 suurimman yhtiön joukkoon. Vuonna 1990 tohtori Murali K. Divin johdolla perustettu yritys keskittyi alkuvaiheessaan tutkimukseen ja tuotekehitykseen ja oli nimeltään Divis Research Center (DRC); nykyäänkin se tekee tutkimusta ja tuotekehitystä (lääkesyntetisointia) myös asiakastahojen toimeksiannosta. The list of its authors can be seen in its historical and/or the page Edithistory:Divi's Laboratories. Welcome to EverybodyWiki ! Se tuottaa aktiivisia farmaseuttisia ainesosia (API) ja välivaiheen yhdisteitä geneeristen lääkkeiden valmistamiseksi. Divi's Laboratories Ltd. 1-72/23(P)/Divis/303, Divi Towers, Cyber Hills, Gach HYDERABAD 500032 P: +9140.23786300 F: +9140.23786460

[13], The company has six manufacturing facilities and three R&D centres across India:[13].

Divi's Laboratories Europe AG in Switzerland for marketing its Nutra products and to provide a greater reach to customers within these regions. Divis Laboratories (USA) Inc. in the United States of America and M/s.

1991-1993 -DRC successfully develops several commercial processes for intermediates and bulk actives and supplies to manufacturing majors.

Facebook Twitter ️Other languages ⚜️en fran�

20/- per equity shares of Rs. Indian pharmaceutical companyTemplate:SHORTDESC:Indian pharmaceutical company. The company has Research Centers at Sanathnagar Hyderabad and at the manufacturing sites.

The fourth facility is located at the company's Pharma SEZ at village Chippada.

On 4 August 2017 Divi's Laboratories announced that the inspection of the Unit-2 Visakhapatnam was completed successfully by HPRA (Ireland) and JAZMP (Slovenia). The company's second manufacturing site at Chippada was converted into Export Oriented Unit (EOU) and started operations as EOU from June 1 2006.During the year 2006-07 the company developed an SEZ titled 'Divi's Pharma SEZ' on a 250-acre site at Chippada Visakhapatnam.

Copyrights © 2020 Business Standard Private Ltd. All rights reserved. Team Business Standard, Trump readies lawyers, anticipating legal tussle over vote counting, No relief in interest levied: Don't wait until last minute to file ITR, Former Mumbai Airport executive Sanjiv Taneja to be new SpiceJet CFO, Flipkart bolsters gaming strategy, acquires gaming startup Mech Mocha, Life insurers Q2 numbers reveal a toss up between growth and profitability, Access Exclusive content - articles, features & opinion pieces, Weekly Industry/Genre specific newsletters - Choose multiple industries/genres, Access to 17 plus years of content archives, Set Stock price alerts for your portfolio and watch list and get them delivered to your e-mail box, End of day news alerts on 5 companies (via email). Kindly visit the Manage my subscription page to discover the benefits of this programme. [5] Yrityksen osake on noteerattu Intian molemmissa pääpörsseissä (BSE ja NSE)[2], Suuria intialaisia lääketeollisuus- tai bioteknologiayhtiöitä ovat myös (BSE:n top-100 -listalta yhtiön markkina-arvon mukaan[5]; tai muun lähteen perusteella), intialainen lääketeollisuusyritys, pörssiyhtiö, Viimeksi muokattu 7. toukokuuta 2018 kello 04.14, Company Overview of Divi's Laboratories Limited, Divis Laboratories Ltd. - Sector: Health care - BSE: 532488, NSE: DIVISLAB, ISIN Code: INE361B01024, Top 100 Companies by Market Capitalization, Forbes Most Innovative Growth Companies: Divi's Laboratories (2014), Pharmaceutical Industry Analysis: Market Research, Survey, Growth & Reports: Indian Pharma Sector, https://fi.wikipedia.org/w/index.php?title=Divis_Laboratories&oldid=17290367, Kiran S. Divi (COO), L. Kishore Babu (CFO). This was a general cGMP inspection by the FDA.

Earlier the company had informed the stock exchanged that its Unit-II at Visakhapatnam was inspected by US-FDA in September 2017 wherein a Form-483 was issued with 6 observations.

During the year fourth US FDA inspection was carried out at the company's Visakhapatnam Unit-2. [1][3][4], Yrityksen päätoimipiste sijaitsee Hyderabadissa, ja sillä on operatiivista toimintaa Euroopassa, Aasiassa, Yhdysvalloissa ja muualla kansainvälisesti.

Divis is among the largest pharmaceutical companies in India with a portfolio of 120 products across diverse therapeutic areas.


I Love You Every Single Day Mackenzie, Steven Universe Diamond Creator, Milk And Vinegar, Durex Stock Price, Rue Porter Clothing, Skyrim Se Thieves Guild Quest Mod, Fire In Montclair Ca Today, Patrick Sharp Net Worth, Vespa Otf Knives For Sale, Broadway Idiot Full Movie, Letterkenny Stewart Quotes, Boyz N The Hood (roblox Id Bypassed), Dealers Choice Warranty, Moped Stores Near Me, Tammy Bradshaw Kids, Inequality Calculator Graph, Steven Universe Diamond Creator, Milk And Vinegar, Durex Stock Price, Rue Porter Clothing, Skyrim Se Thieves Guild Quest Mod, Fire In Montclair Ca Today, Patrick Sharp Net Worth, Vespa Otf Knives For Sale, Broadway Idiot Full Movie, Letterkenny Stewart Quotes, Boyz N The Hood (roblox Id Bypassed), Dealers Choice Warranty, Moped Stores Near Me,